Pfizer and BioNTech Studying Third Covid-19 Vaccine Dose to Fight New Strains

Pfizer and BioNTech Studying Third Covid-19 Vaccine Dose to Fight New Strains

The companies have begun a study in people testing whether a third dose of their vaccine would increase its effectiveness against the variant identified in South Africa and other strains.